Kim S K, Cuzzort L M, McKean R K, Allen E D
Research Service, VA Medical Center, Ann Arbor 48105.
J Dent Res. 1990 Aug;69(8):1500-4. doi: 10.1177/00220345900690081001.
Previous studies have shown that amylase levels are reduced significantly in the pancreas and parotid gland of diabetic rats and that insulin reverses this effect and increases the secretory protein levels. In the pancreas, these changes in amylase protein levels are accompanied by parallel changes in amylase mRNA levels. In the present study, the effects of diabetes and subsequent insulin treatments on contents (per cell) of amylase protein and its mRNA in parotid glands were compared in rats rendered diabetic with an injection of a beta-cell toxin, streptozotocin (STZ). Both amylase protein and its mRNA contents were reduced significantly in diabetic rats, compared with control rats, and this reduction was reversed following insulin injections of diabetic rats. In insulin-injected diabetic rats, amylase protein contents increased before a detectable increase in amylase mRNA levels was seen. The mRNA contents of a non-secretory protein, actin, did not change during diabetogenesis or subsequent insulin treatments. The reductions in parotid contents of amylase and its mRNA in diabetic rats and the reversal of these changes by insulin are similar to those changes that occur in the pancreas under the same conditions. However, the magnitude of these changes in parotid glands was much smaller than in the pancreas, and the effect of insulin on amylase mRNA synthesis was not as immediate as in the latter gland.
先前的研究表明,糖尿病大鼠的胰腺和腮腺中淀粉酶水平显著降低,胰岛素可逆转这种效应并提高分泌蛋白水平。在胰腺中,淀粉酶蛋白水平的这些变化伴随着淀粉酶mRNA水平的平行变化。在本研究中,对注射β细胞毒素链脲佐菌素(STZ)诱导糖尿病的大鼠,比较了糖尿病及随后胰岛素治疗对腮腺中淀粉酶蛋白及其mRNA含量( per cell)的影响。与对照大鼠相比,糖尿病大鼠的淀粉酶蛋白及其mRNA含量均显著降低,而糖尿病大鼠注射胰岛素后这种降低得到逆转。在注射胰岛素的糖尿病大鼠中,在淀粉酶mRNA水平出现可检测到的增加之前,淀粉酶蛋白含量就增加了。非分泌蛋白肌动蛋白的mRNA含量在糖尿病发生过程或随后的胰岛素治疗期间没有变化。糖尿病大鼠腮腺中淀粉酶及其mRNA含量的降低以及胰岛素对这些变化的逆转与相同条件下胰腺中发生的变化相似。然而,腮腺中这些变化的幅度远小于胰腺,并且胰岛素对淀粉酶mRNA合成的作用不如在胰腺中那样迅速。